Epidemiology of diabetes and diabetic complications in China
- PMID: 29392352
- DOI: 10.1007/s00125-018-4557-7
Epidemiology of diabetes and diabetic complications in China
Erratum in
-
Correction to: Epidemiology of diabetes and diabetic complications in China.Diabetologia. 2018 Jun;61(6):1491. doi: 10.1007/s00125-018-4616-0. Diabetologia. 2018. PMID: 29700561
Abstract
The People's Republic of China (herein referred to as China) has witnessed one of the most dramatic rises in diabetes prevalence anywhere in the world. The latest epidemiological study suggests that approximately 11% of the population has diabetes, with a significant proportion remaining undiagnosed. Risk factors for diabetes in the Chinese population are similar to those in other populations, though gestational diabetes and young-onset diabetes is becoming increasingly common. Data on the prevalence of diabetic complications remain limited, though cardio-renal complications account for significant morbidity and mortality. Other diabetes-related comorbidities are becoming increasingly common, with cancer emerging as a major cause of mortality among individuals with diabetes. There are many challenges and obstacles that impede effective diabetes prevention and the delivery of care, though much progress has occurred over recent years. Lessons learnt from how China has responded to the challenges posed by the diabetes epidemic will be invaluable for other countries facing the many threats of diabetes and its complications.
Keywords: China; Coronary heart disease; Diabetes; Diabetic kidney disease; Epidemiology; Genetics; Gestational diabetes; Obesity; Review; Risk factors.
Similar articles
-
Diabetes in sub-Saharan Africa.Lancet. 2010 Jun 26;375(9733):2254-66. doi: 10.1016/S0140-6736(10)60550-8. Lancet. 2010. PMID: 20609971 Review.
-
[Epidemiology of diabetes in the elderly].Rev Invest Clin. 2010 Jul-Aug;62(4):305-11. Rev Invest Clin. 2010. PMID: 21222308 Review. Spanish.
-
Diabetes mellitus and its complications in India.Nat Rev Endocrinol. 2016 Jun;12(6):357-70. doi: 10.1038/nrendo.2016.53. Epub 2016 Apr 15. Nat Rev Endocrinol. 2016. PMID: 27080137 Review.
-
Diabetes mellitus epidemiology-classification, determinants, and public health impacts.J Miss State Med Assoc. 2004 Dec;45(12):355-62. J Miss State Med Assoc. 2004. PMID: 15638167 Review.
-
Epidemiology, complications and management of diabetes in Ethiopia: a systematic review.J Diabetes. 2012 Jun;4(2):174-80. doi: 10.1111/j.1753-0407.2011.00181.x. J Diabetes. 2012. PMID: 22212307 Review.
Cited by
-
Flexible electrical stimulation device with Chitosan-Vaseline® dressing accelerates wound healing in diabetes.Bioact Mater. 2020 Aug 19;6(1):230-243. doi: 10.1016/j.bioactmat.2020.08.003. eCollection 2021 Jan. Bioact Mater. 2020. PMID: 32913931 Free PMC article.
-
ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Study.Diabetes Ther. 2024 Oct;15(10):2183-2196. doi: 10.1007/s13300-024-01617-3. Epub 2024 Jul 15. Diabetes Ther. 2024. PMID: 39008234 Free PMC article.
-
AI-based prediction for the risk of coronary heart disease among patients with type 2 diabetes mellitus.Sci Rep. 2020 Sep 2;10(1):14457. doi: 10.1038/s41598-020-71321-2. Sci Rep. 2020. PMID: 32879331 Free PMC article.
-
Clinical and MRI features about two types of silent cerebral small-vessel disease in type-2 diabetes mellitus: a retrospective cross-sectional study in a tertiary hospital.Quant Imaging Med Surg. 2022 Apr;12(4):2385-2396. doi: 10.21037/qims-21-786. Quant Imaging Med Surg. 2022. PMID: 35371929 Free PMC article.
-
_targeting ferroptosis with miR-144-3p to attenuate pancreatic β cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes.Diabetol Metab Syndr. 2022 Jun 27;14(1):89. doi: 10.1186/s13098-022-00852-7. Diabetol Metab Syndr. 2022. PMID: 35761309 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical